cancer clinical trials in durham, NC
Duke Comprehensive Cancer Center
Durham, North Carolina 27710 Breast Cancer, Carcinoma of the Breast
|
Duke Univ Medical Center
Durham, North Carolina 27710 Adenocarcinoma
|
Duke Comprehensive Cancer Center
Durham, North Carolina 27710 Lung Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Extraocular Retinoblastoma
|
Duke Cancer Institute
Durham, North Carolina 27710 Leukemia
|
Duke University Medical Center
Durham, North Carolina 27710 Prostate Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
|
Duke University Medical Center
Durham, North Carolina 27710 Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
|
Duke University
Durham, North Carolina 27710 Breast Cancer, Bone Metastases
|
Duke Cancer Institute
Durham, North Carolina 27710 Neuroblastoma
|
Durham VA Medical Center, Durham, NC
Durham, North Carolina 27705 Cancer, Prostate
|
Duke University Medical Center
Durham, North Carolina 27710 Acute Lymphoblastic Leukemia, Brain Tumors
|
Duke University Comprehensive Cancer Center
Durham, North Carolina 27710 Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Lymphoma, B-Cell
|
Duke University Health Systems
Durham, North Carolina 27710 Lymphoma, Myeloma, Leukemia, Myelodysplasia, Solid Tumors
|
Duke University Health Systems
Durham, North Carolina 27710 Lymphoma, Myeloma, Leukemia, Myelodysplasia, Solid Tumors
|
Duke University Medical Center
Durham, North Carolina 27710 Healthy
|
Duke University Medical Center
Durham, North Carolina 27710 Solid Tumors
|
Duke University Health System
Durham, North Carolina 27705 Lymphoma
|
Duke University Health Systems
Durham, North Carolina 27710 Lymphoma
|
Duke University Health System
Durham, North Carolina 27705 Glioblastoma, Gliosarcoma, Brain Tumor
|
Duke University Health System
Durham, North Carolina 27705 Hodgkin's Disease, Non Hodgkin's Lymphoma, Myeloma, Leukemia, Myelodysplasia
|
Duke University Health System
Durham, North Carolina 27705 Lymphoma, Myeloma, Leukemia, Myelodysplasia, Solid Tumors, Hodgkin's Disease, Myelofibrosis
|
Duke University Health System
Durham, North Carolina 27705 Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma
|
Duke University Health System
Durham, North Carolina 27705 Glioblastoma, Gliosarcoma
|
Duke University Health System
Durham, North Carolina 27705 Glioblastoma, Gliosarcoma
|
Duke University Medical Center
Durham, North Carolina 27710 Liver Transplantation
|
Duke University Medical Center
Durham, North Carolina 27710 Malignant Neoplasms of Brain
|
Duke University Medical Center
Durham, North Carolina 27710 Malignant Neoplasms Brain
|
Duke University Medical Center
Durham, North Carolina 27710 Hepatic Veno-Occlusive Disease
|
Duke Cancer Institute
Durham, North Carolina 27710 Lung Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Brain Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Malignant Neoplasms of Brain
|
Duke University Medical Center
Durham, North Carolina 27710 Malignant Neoplasms of Brain
|
Duke University Medical Center
Durham, North Carolina 27710 Venous Thrombosis
|
Duke Comprehensive Cancer Center
Durham, North Carolina 27710 Leukemia
|
Duke Comprehensive Cancer Center
Durham, North Carolina 27710 Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS), B Cell Malignancies
|
Duke University Medical Center
Durham, North Carolina 27710 Metastatic Melanoma, Absence of CNS Metastases
|
Duke University Medical Center
Durham, North Carolina 27710 Prostate Cancer, Prostatectomy
|
Duke University
Durham, North Carolina 27710 Venous Thrombosis
|
Duke Cancer Institute
Durham, North Carolina 27710 Retinoblastoma
|
Duke University Medical Center
Durham, North Carolina 27710 Multiple Myeloma
|
Duke University Medical Center
Durham, North Carolina 27710 Glioblastoma
|
Duke University Medical Center
Trial Locations Duke University Medical Center Durham Veterans Affairs Medical Center Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Non Small Cell Lung Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Adenovirus Infection, EBV Infection
|
Duke University Medical Center
Durham, North Carolina 27710 Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
|
Duke Cancer Institute
Durham, North Carolina 27710 Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
|
Duke University Medical Center
Durham, North Carolina 27710 Prostate Cancer
|
Duke Cancer Institute
Durham, North Carolina 27710 Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
|
Duke Cancer Institute
Durham, North Carolina 27710 Colorectal Cancer
|
1200.36.0001 Boehringer Ingelheim Investigational Site
Durham, North Carolina Glioma
|
Duke University
Durham, North Carolina 27710 Primary Progressive Multiple Sclerosis
|
Duke University Medical Center
Durham, North Carolina 27710 Breast Cancer
|
Duke University
Durham, North Carolina 27710 Prostate Cancer
|
Duke University Medical Center
Durham, North Carolina 27710 Partial Mastectomy, Lumpectomy, Mastectomy
|
Duke University Medical Center
Durham, North Carolina 27710 Acute Lymphoblastic Leukemia, Brain Tumor, Working Memory Deficits
|
Duke University Medical Center
Durham, North Carolina 27710 Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
Duke University Medical Center
Durham, North Carolina 27710 Non-Small Cell Lung Cancer, Prostate Cancer, Pancreatic Cancer
|
Duke Comprehensive Cancer Center
Durham, North Carolina 27710 Multiple Myeloma and Plasma Cell Neoplasm
|
Duke University Medical Center
Durham, North Carolina 27710 Prostatic Neoplasms
|
Duke University Medical Center
Durham, North Carolina 27710 Sickle Cell Disease
|
Duke University Medical Center
Durham, North Carolina 27710 Graft vs Host Disease, Graft-Versus-Host Disease
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Durham, North Carolina Non-small Cell Lung Cancer
|
Duke Comprehensive Cancer Center
Durham, North Carolina 27710 Breast Cancer, Menopausal Symptoms
|
Duke University Medical Center
Durham, North Carolina 27710 Glioblastoma Multiforme
|
Duke University Medical Center
Durham, North Carolina 27710 Melanoma
|
Duke University Medical Center
Durham, North Carolina 27710 Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
Duke University Medical Center
Durham, North Carolina 27710 Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Duke University Medical Center
Trial Locations Duke University Medical Center Durham VA Medical Center Non Small Cell Lung Cancer
|